Context
The Maharashtra FDA (Food and Drug Administration) issued a stop production order and instructed the withdrawal of export NoCs (No Objection Certificates) and manufacturing licenses for any combination of Tapentadol and Carisoprodol.
While these two drugs are approved separately in India, their combination is not approved by the Central Drugs Standard Control Organisation (CDSCO), India's drug regulatory authority.
Central Drugs Standard Control Organisation (CDSCO)
|
Verifying, please be patient.